Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP951621priorityCriticalpatent/ECSP951621A/es
Publication of ECSP951621ApublicationCriticalpatent/ECSP951621A/es
208000037265diseases, disorders, signs and symptomsDiseases0.000abstract1
208000035475disorderDiseases0.000abstract1
239000003112inhibitorSubstances0.000abstract1
Landscapes
Plural Heterocyclic Compounds
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Compuestos de fórmula (I) donde R -R , A y B tienen el significado dado en la descripción, son inhibidores de la endotelina y puede ser utilizado para el tratamiento de los trastornos que se asocian con las actividades de la endotelina, como el alto la presión arterial.
ECSP9516211995-12-191995-12-19Nuevas sulfonamidas case ran 4019/132
ECSP951621A
(es)